We have occasionally discussed on this site (as recently as this week…) the implications of interconnected devices and the Internet of Things.
Here is an article that asks “should cyber-security vulnerabilities really be treated the same as design defects under traditional products liability law?”
The specific context is an infusion pump system that the Federal Drug Administration in the US thought was insecure and sent a warning about – a warning that sounded like a ‘defective product’ warning. The article raises a number of concerns about thinking about a security defect like another defect, including many complications about who . . . [more]